Discounted Cash Flow Rating

Buy

Return on Equity Rating

Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Neutral

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

ACELYRIN, INC. Common Stock (SLRN)

Pharmaceutical Preparations

https://www.acelyrin.com

Acelyrin Inc is a late-stage clinical biopharmaceutical company. It is focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of promising drug candidates.

4149 LIBERTY CANYON RD.
AGOURA HILLS, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/05/2023

Market Cap

399,732,105

Shares Outstanding

97,340,000

Weighted SO

97,339,494

Total Employees

N/A

Upcoming Earnings

08/12/2024

Similar Tickers

Beta

0.0000

Last Div

0.0000

Range

3.36-29.88

Chg

0.0250

Avg Vol

1120674

Mkt Cap

399732105

Exch

NASDAQ

Country

US

Phone

805-730-0360

DCF Diff

0.8724

DCF

3.0876

Div Yield

0.0000

P/S

2408.0247

EV Multiple

-0.7267

P/FV

0.6989

Div Yield %

0.0000

P/E

-1.3247

PEG

-0.0238

Payout

0.0000

Current Ratio

7.8623

Quick Ratio

7.8623

Cash Ratio

1.5550

DSO

12139.5482

DIO

0.0000

Op Cycle

12139.5482

DPO

57388.1467

CCC

-45248.5985

Gross Margin

-0.5602

Op Margin

-2261.0482

Pretax Margin

-1806.0060

Net Margin

-1806.0060

Eff Tax Rate

0.0993

ROA

-0.4600

ROE

-0.8129

ROCE

-0.6593

NI/EBT

1.0000

EBT/EBIT

0.7987

EBIT/Rev

-2261.0482

Debt Ratio

0.0016

D/E

0.0019

LT Debt/Cap

0.0019

Total Debt/Cap

0.0019

Int Coverage

0.0000

CF/Debt

-202.3658

Equity Multi

1.1470

Rec Turnover

0.0301

Pay Turnover

0.0064

Inv Turnover

0.0000

FA Turnover

0.0636

Asset Turnover

0.0003

OCF/Share

-2.1816

FCF/Share

-2.1933

Cash/Share

6.4061

OCF/Sales

-1303.1867

FCF/OCF

1.0054

CF Coverage

-202.3658

ST Coverage

0.0000

CapEx Coverage

-185.8497

Div&CapEx Cov

-185.8497

P/BV

0.6989

P/B

0.6989

P/S

2408.0247

P/E

-1.3247

P/FCF

-1.8379

P/OCF

-1.8358

P/CF

-1.8358

PEG

-0.0238

P/S

2408.0247

EV Multiple

-0.7267

P/FV

0.6989

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Apr 04, 23:00 $HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger – OPTN, SLRN, AKYA, SHYF GlobeNewswire Inc. Dec 20, 16:30 ACELYRIN, INC. Appoints Lynn Tetrault to Board of Directors GlobeNewswire Inc. Dec 20, 16:30 ACELYRIN, INC. Appoints Lynn Tetrault to Board of Directors GlobeNewswire Inc. Nov 27, 16:30 ACELYRIN, INC. Provides Update on Izokibep Clinical Development Program GlobeNewswire Inc. Nov 27, 16:30 ACELYRIN, INC. Provides Update on Izokibep Clinical Development Program GlobeNewswire Inc. Oct 31, 16:30 ACELYRIN, INC. to Report Third Quarter 2023 Financial Results and Corporate Update on November 7, 2023

Revenue Product Segmentation